LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia
Category: News
Accreditation recognises ‘continued professional development’ opportunities
The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
The new technology can generate a target infection within 30 minutes to two hours
The most globally prevalent cancers include breast, lung, bowel and prostate cancers
Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK
The progressive neurodegenerative condition affects around 153,000 people in the UK
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress